TRIUMPH CAPITAL MANAGEMENT iShares Genomics Immunology and Healthcare ETF Transaction History

TRIUMPH CAPITAL MANAGEMENT portfolio value:

$0
portfolio value

TRIUMPH CAPITAL MANAGEMENT quarter portfolio value change:

-8.69%
quarter

iShares Genomics Immunology and Healthcare ETF 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -18.38K shares -160K $26.39 0
Q2 2022 share Increase 0.00% 18.38K shares 160K $28.9 18.38K